Your browser doesn't support javascript.
loading
Longitudinal change in lung function and subsequent risks of cardiovascular events: evidence from four prospective cohort studies.
Cheng, Yun-Jiu; Chen, Zhen-Guang; Li, Zhu-Yu; Mei, Wei-Yi; Bi, Wen-Tao; Luo, Dong-Ling.
Afiliación
  • Cheng YJ; Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510700, China. chyjiu@mail.sysu.edu.cn.
  • Chen ZG; NHC Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou, China. chyjiu@mail.sysu.edu.cn.
  • Li ZY; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Mei WY; Department of Obstetrics and Gynecology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Bi WT; Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510700, China.
  • Luo DL; NHC Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou, China.
BMC Med ; 19(1): 153, 2021 07 02.
Article en En | MEDLINE | ID: mdl-34210292
BACKGROUND: Lung function is constantly changing over the life course. Although the relation of cross-sectional lung function measure and adverse outcomes has been reported, data on longitudinal change and subsequent cardiovascular (CV) events risks are scarce. Therefore, this study is to determine the association of longitudinal change in lung function and subsequent cardiovascular risks. METHODS: This study analyzed the data from four prospective cohorts. Subjects with at least two lung function tests were included. We calculated the rate of forced respiratory volume in 1 s (FEV1) and forced vital capacity (FVC) decline for each subject and categorized them into quartiles. The primary outcome was CV events, defined as a composite of coronary heart disease (CHD), chronic heart failure (CHF), stroke, and any CV death. Cox proportional hazards regression and restricted cubic spline models were applied. RESULTS: The final sample comprised 12,899 participants (mean age 48.58 years; 43.61% male). Following an average of 14.79 (10.69) years, 3950 CV events occurred. Compared with the highest FEV1 quartile (Q4), the multivariable HRs for the lowest (Q1), 2nd (Q2), and 3rd quartiles (Q3) were 1.33 (95%CI 1.19, 1.49), 1.30 (1.16, 1.46), and 1.07 (0.95, 1.21), respectively. Likewise, compared with the reference quartile (Q4), the group that experienced a faster decline in FVC had higher HRs for CV events (1.06 [95%CI 0.94-1.20] for Q3, 1.15 [1.02-1.30] for Q2, and 1.28 [1.14-1.44] for Q1). The association remained robust across a series of sensitivity analyses and nearly all subgroups but was more evident in subjects < 60 years. CONCLUSIONS: We observed a monotonic increase in risks of CV events with a faster decline in FEV1 and FVC. These findings emphasize the value of periodic evaluation of lung function and open new opportunities for disease prevention.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: China
...